Hepatic resection is justified for elderly patients with hepatocellular carcinoma

Kazuhiro Kondo1, Kazuo Chijiiwa, Mayumi Funagayama

  • 1Department of Surgical Oncology and Regulation of Organ Function, Miyazaki University School of Medicine, 5200 Kihara, Kiyotake, Miyazaki, Japan.

Insights

Hepatic resection for hepatocellular carcinoma (HCC) is safe and effective for patients aged 70 and older, showing similar outcomes to younger patients. This supports surgical intervention for selected elderly individuals with HCC.

Area of Science:

  • Hepatobiliary surgery
  • Surgical oncology
  • Geriatric medicine

Background:

  • Hepatocellular carcinoma (HCC) is a common liver cancer.
  • Hepatic resection is a primary treatment for HCC.
  • Elderly patients often avoid surgery due to perceived risks.

Purpose of the Study:

  • To evaluate the safety and efficacy of hepatic resection in elderly patients (≥70 years) with HCC.
  • To compare surgical outcomes between elderly and younger HCC patients.

Main Methods:

  • Retrospective study of 294 patients undergoing 319 hepatic resections for HCC.
  • Patients divided into two groups: ≥70 years (n=109) and <70 years (n=210).
  • Comparison of postoperative complications (Clavien system), survival rates (JIS scores), and HCC-related death rates.

Main Results:

  • No significant differences in postoperative complications or severity between age groups.
  • Similar postoperative survival rates and HCC-related death rates across both age groups.
  • Differences noted in performance status and hepatitis virus infection types.

Conclusions:

  • Hepatic resection is a viable and safe treatment option for selected elderly patients (≥70 years) with HCC.
  • Surgical indications for younger HCC patients are applicable to the elderly.
  • Outcomes suggest elderly patients can benefit from hepatic resection without increased risk.
Abstract

Related Concept Videos